* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 128. immune_team_
Immune system wikipedia , lookup
DNA vaccination wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Adaptive immune system wikipedia , lookup
Molecular mimicry wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Innate immune system wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Complement system wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Sjögren syndrome wikipedia , lookup
X-linked severe combined immunodeficiency wikipedia , lookup
Immunodeficiency diseases. Prof. Mohamed Osman GadElRab. College of Medicine & KKUH. Introduction. • Immunodeficiency diseases are : A diverse spectrum of illnesses due to various abnormalities of the immune • Prevalence : Primary (congenital) 1 : 10,000 to 1 : 200,000 present at birth . Secondary (acquired) is more common . Overview of Immunodeficiency Disorders. The defect might be In the level of stem cell or in any other level of tree Clinical manifestations. ( is increased susceptibility to infections ) The patient is considered to have I.D. if the infections are : Frequent & severe. Caused by opportunistic Infections. Resistant to antimicrobial therapy. Since the main presentation is infection, It is critical to maintain an index of suspicion to diagnose I.D. Important : Early diagnosis & management reduce morbidity (disease). Classification : Primary (congenital). Secondary (acquired). Its common malnutrition. Genetic mutations. Genetic polymorphism. They could be : Most important cause viral & bacterial infections. e.g. AIDS which is caused by HIV either Monogenic ( defect in one gene ) or polygenic ( defect in more than one gene ) Immunosuppressive drugs. (corticosteroids). For long-time use, it’ll depress the immune system excessive protein loss, burns, nephrotic syndrome ( loss of cells like RBC and loss of protein liek Ig ) Primary or acquired. can affect. Natural immunity (non-specific body defenses). Phagocytic cells. Complement proteins. Acquired immunity. (specific body defenses). T-cells. B-cells. SCID. Combined T& B cells (SCID). T-cell. T-cell. B-cell. B-cell. Phagocyte. Phagocytes. • The severe combined immunodeficiency is characterized by effecting both B- and T- cells B-cell defects. Gammaglobulinaemias: Properties of B-cell defects 1. Diverse spectrum of diseases ranging from: Complete absence of B-cells , Plasma cells and Immunoglobulin's , to selective absence of certain immunoglobulin classes 2. • • • X- linked disease : If heterozygous Female carriers are normal . Males manifest the disease . 3. Severity of the disorder parallels ( is Proportional to ) the degree of deficiency . the ] FEATURES OF B-CELL DEFECT [ - Reduced B-cell counts to 0.1 percent ( normally 5-15 percent .) - Absence of Immunoglobulins . - Small Lymph nodes , no germinal centers ( the home of B-cells in the lymph node ) Early B-cell differentiation . Lesions can occur at any site in the pathway of B-cell development. B-cell defect could be in any level in the pathway IMPORTANT Patients with B-cell defects are subject to: Recurrent bacterial infections but Display normal immunity to most viral & fungal infections. because : T-cells are unaffected. Because T-cell which stands in the face of viral and fungal infection ( The disease ) ( the level of defect ) 1. X-linked Bruton tyrosine agammaglobulinaemia. Kinase (Btk) ( the result ) no mature B-cells. Is the first I.D. Recognized in (1952) The most common ( 80 to 90 percent ) Defect in Bruton tyrosine kinase enzyme (BTK). The Defect involve a block in maturation of pre- B- cells to mature B- cells in marrow. Pre B-cell + BTK enzyme Mature B-cell bone Features of XLA.: - Reduced B-cell counts to 0.1 percent ( normally 5-15 percent .) - Absence of Immunoglobulins . - Small L.nodes , no germinal centers . X-linked agammaglobulinaemia. (XLA) .cont. . Affected children suffer from recurrent pyogenic bacterial infections of : : ( conjunctiva , throat, skin , ear, bronchi & lung ) Infecting microbes include :Pneumococci, H.influenzae Streptococci. Also the patient is susceptible to certain viruses ( polio) and intestinal parasites (giardia ). X-linked agammaglobulinaemia. (XLA) .cont. * . Most intracellular microbes & fungi are handled normally by (T- cells ). 2. Selective immunoglobulin deficiency. 1. IgA deficiency (1:700) Most are asymptomatic , but have increased rate of ( respiratory tract infection R.T.I ) Some have recurrent R.T.I. and G.I.T. Symptoms Because of lack of secretion of IgA on the mucous membrane of GIT and respiratory tract . ] Increased incidence of allergic manifestations [ anti - convlusant drugs (phenytoin) may cause secondary deficiency ( these drugs are used to treat epilepsy, they destroy IgA ) X- linked hyper-IgM Syndrome. Characterized by : - Low IgG, IgA & IgE - Markedly elevated IgM - High levels of autoantibodies (against neutrophils , platelets , red cells ) ] So, low levels of RBCs, neutrophils, and platelets [ Recurrent infections especially Pneumocystis carinii ] Pneumocystis carinii usually found in people who have AIDS [ X-linked hyper-IgM Syndrome. (cont.) هاااااااام جدا جدا Defect in the CD 40L in T- cells lead to : ( CD 40L is the hand that Th cell use it to shake other cells hands ) * No co-stimulatory signal for B-cells. * No response to T-dependent antigens . * No class – switching. ( The change of one class of Ig to another one ) * No memory cells. * Marked lymphadenopathy . ( The disease ) 3. X-linked hyper-IgM Syndrome. ( the level of defect ) defective CD40 Ligand. ( the result ) markedly elevated IgM. Management of immunoglobulin deficiencies : repeated intravenous immunoglobulin (IV Ig) reduces infectious complications . --- GIVE Ig --- T- cell defects. DiGeorge Syndrome : ( congenital thymic aplasia ) First described in 1952 • Characterized by : - Absence of the Thymus gland . ( So , no T-cells in the body ) - Hypoparathyroidism Which lead to tetany - Cardiovascular abnormalities and Characteristic facial features ] Because they appear from the same embryologic origin of the thymus ( 3-4 pharyngeal pouches) so they are involved [ DiGeorge syndrome : Failure of the third & fourth pharyngeal pouches to develop . *Features : -Children may present with ( tetany) seizures -Extreme susceptibility to viral , protozoal, and fungal infections. ( Because of no T-cell ) So : 1. profound depression of T-cell numbers. 2. absence of T-cell responses. DiGeorge syndrome : In some cases B-cells are normal and produce effective humoral immunity to bacterial infections . (Partial Di George Syndrome.) ( thymic hypoplasia, Nezelof syndrome ). There’s a little number of circulating T-cell but B-cells are normal In some T-cell – dependant antibody production is absent .( no helper T- cells ). DiGeorge syndrome ; • Management: Fetal thymus tissue graft (14 week old). steps should be taken to prevent G.V.H. ( graft versus host ) Reactions G.V.H. Reactions : the transplanted thymus or bone marrow recognize the host body cells as foreign body’s cells and attack it Severe combined immunodeficiency. (SCID ). Both T and B cells are defected Severe combined I.D. : Features: 1. Increased susceptibility to viral, fungal , bacterial & protozoal infection. ( start at 3 month of age ) 2. Failure to thrive. 3. Reduced weight gain. 4. Prolonged diarrhea. 5. Moniliasis due to candida . Severe combined immunodeficiency (SCID ) : in Autosomal recessive SCID - ADA deficiency . Lead to - PNP deficiency. ( ADA and PNP are missing enzymes) toxic metabolites in T & B-cells. Management of recessive (SCID.) 1. Infusion of purified enzymes. 2. Gene therapy . Leukocyte defects. Its either : Quantitative. ( amount ) Qualitative. ( function ) Quantitative. 1. Congenital agranulocytosis : ] Kostmann syndrome [ Defect in the gene inducing G-CSF (granulocyte colony stimulating factor) it is a stimulatory factor that acts on bone marrow to produce WBCs, so if its defected, the amount will decrease Features: pneumonia ,otitis media, gingivostomatitis perineal abscesses Management: Respond to G-CSF therapy ( gene therapy ) Phagocyte defects. Qualitative. 1.Defect in response to chemotactic agents. 2.Defect in intracellular killing. A . Defect in chemotaxis: Leukocyte adhesion deficiency (LAD.) B. Defect in intracellular killing: 1.Chronic granulomatous disease: x-linked. (75%) autosomal recessive .(25%). DEFECT: in the oxidative complex . ( responsible for producing superoxide radicals .) FEATURES: Extreme susceptibility to infections. Granulomatous inflammation. (chronic T-cell stimulation.) Complement deficiency. Deficiency of all complement components have been described C1-C9. 1. Deficiency of C1, C2 & C4. ( classical pathway ) lead to immune-complex diseases which can cause significant pathology in autoimmune diseases. ] N.B : immune-complex = antibody - antigen interaction [ Pathways of complement activation. CLASSICAL PATHWAY LECTIN PATHWAY antibody dependent ALTERNATIVE PATHWAY antibody independent Activation of C3 and generation of C5 convertase activation Of C5 LYTIC ATTACK PATHWAY • The main component that needs to be activated is C3 , All pathways activate C3 classic alternative lactin C3 • C3 then activates C5 and divide into C3a and C3b • C5 then activate ( membrane - attack complex) and divide into C5a and C5b • In classic pathway : • C1 activates C2 which activates C4 finally activates C3 4. Deficiency of membrane - attack complex. (MAC). ( C5 - C9 ) Lead to infection with N.meningitides and N.gonorrhea . 5. Deficiency of • • C3 ( the central point of complement ) ] no complement proteins [ Lead to infections with pyogenic bacteria. impaired clearance of immune-complexes. . C1 - inhibitor deficiency: hereditary angioedema C1 - inhibitor deficiency: ( hereditary angioedema ) • Is a deficiency of an enzyme which is responsible for prevention of ] C1 self-activation [ • because it’ll attack the body’s own cells, and cause inflammation usually in the ] uvula [ which leads to choking till death. • So these patients always have adrenaline in their pockets to prevent the swallowing • So the enzyme makes C1 activated only against pathogens. 4. Laboratory evaluation. 1. Complete blood count (total & differential). 2. Evaluation of antibody responses :A. determination of serum immunoglobulins B. measure specific antibody responses : -To polysaccharide antigens. ( measure isohemagglutinins. ) - To protein antigens . ( measure antibodies to tetanus .) 3. Determination of T & B cell counts. ( by flow cytometry ) 4. Determination of the complement components. C3, C4 . - assess functional activity by CH50 5. Assess phagocyte function. - phagocytosis & respiratory burst 6. Carrier detection & prenatal diagnosis ( important for genetic counseling ) • to know which pathway activates the complement : • we check C2 and C3 levels, if both are decreased, it means they have been used a lot , so it’s the classic pathway • If C3 levels are the only reduced means lactin or alternative pathway. HIV virus. T-cell. • )Regarding(GM-CSF)choose the correct answer: used in bone marrow transplant